Aligos Therapeutics
ALGS
ALGS
76 hedge funds and large institutions have $68.4M invested in Aligos Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
82% less capital invested
Capital invested by funds: $390M → $68.4M (-$322M)
96% less call options, than puts
Call options by funds: $2K | Put options by funds: $48K
Holders
76
Holding in Top 10
1
Calls
$2K
Puts
$48K
Top Buyers
| 1 | +$8.29M | |
| 2 | +$3.17M | |
| 3 | +$1.48M | |
| 4 |
Renaissance Technologies
New York
|
+$662K |
| 5 |
IA
IndexIQ Advisors
New York
|
+$415K |
Top Sellers
| 1 | -$36.9M | |
| 2 | -$6.64M | |
| 3 | -$6.19M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$1.52M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$1.5M |